Now, though it is easy to chortle in the ridiculousness of the patent, bad patents have major implications for the entire psychedelics business.“NeonMind’s proprietary preclinical knowledge displays guarantee that both lower and high dose psilocybin may possibly decrease weight achieve and which the reduction in body weight achieve can occur in